1. Home
  2. VIR vs EIG Comparison

VIR vs EIG Comparison

Compare VIR & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • EIG
  • Stock Information
  • Founded
  • VIR 2016
  • EIG 2000
  • Country
  • VIR United States
  • EIG United States
  • Employees
  • VIR N/A
  • EIG N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • EIG Property-Casualty Insurers
  • Sector
  • VIR Health Care
  • EIG Finance
  • Exchange
  • VIR Nasdaq
  • EIG Nasdaq
  • Market Cap
  • VIR 859.9M
  • EIG 986.1M
  • IPO Year
  • VIR 2019
  • EIG 2007
  • Fundamental
  • Price
  • VIR $5.65
  • EIG $39.20
  • Analyst Decision
  • VIR Strong Buy
  • EIG
  • Analyst Count
  • VIR 11
  • EIG 0
  • Target Price
  • VIR $25.73
  • EIG N/A
  • AVG Volume (30 Days)
  • VIR 1.5M
  • EIG 195.9K
  • Earning Date
  • VIR 11-05-2025
  • EIG 10-30-2025
  • Dividend Yield
  • VIR N/A
  • EIG 3.26%
  • EPS Growth
  • VIR N/A
  • EIG N/A
  • EPS
  • VIR N/A
  • EIG 2.58
  • Revenue
  • VIR $16,860,000.00
  • EIG $904,800,000.00
  • Revenue This Year
  • VIR N/A
  • EIG $2.62
  • Revenue Next Year
  • VIR $15.25
  • EIG N/A
  • P/E Ratio
  • VIR N/A
  • EIG $15.22
  • Revenue Growth
  • VIR N/A
  • EIG 1.69
  • 52 Week Low
  • VIR $4.16
  • EIG $35.73
  • 52 Week High
  • VIR $14.45
  • EIG $54.19
  • Technical
  • Relative Strength Index (RSI)
  • VIR 50.14
  • EIG 44.59
  • Support Level
  • VIR $4.82
  • EIG $38.51
  • Resistance Level
  • VIR $5.84
  • EIG $39.59
  • Average True Range (ATR)
  • VIR 0.37
  • EIG 1.07
  • MACD
  • VIR -0.03
  • EIG 0.11
  • Stochastic Oscillator
  • VIR 47.70
  • EIG 64.01

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

Share on Social Networks: